The reiteration of a Buy rating and the maintenance of a $9 price target by a reputable analyst could positively influence investor sentiment towards ASLAN Pharma. This endorsement reaffirms the analyst's confidence in the company's potential, likely encouraging both current and potential investors about the stock's future performance.